| Danielle Lucas, LPN | |
|
190 Match Factory Pl, Bellefonte, PA 16823-1367 | |
| (814) 353-3151 | |
| Not Available |
| Full Name | Danielle Lucas |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist |
| Location | 190 Match Factory Pl, Bellefonte, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720596596 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364S00000X | Clinical Nurse Specialist | PN288505 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Danielle Lucas, LPN 190 Match Factory Pl, Bellefonte, PA 16823-1367 Ph: () - | Danielle Lucas, LPN 190 Match Factory Pl, Bellefonte, PA 16823-1367 Ph: (814) 353-3151 |
News Archive
It is well known that exposure to radiation has multiple harmful effects - including causing cancer - but until now, it has been unclear to what extent such exposure increases a person's risk of developing more than one cancer. The first large-scale study of the relationship between radiation dose and risk of multiple cancers among atomic bomb survivors in Hiroshima and Nagasaki, Japan reveals a similar risk in the development of first and second subsequent cancers.
A new study has found that smokers who take multivitamins offset their healthy behaviour by smoking more cigarettes. This is an example of what psychologists call the licensing effect, which occurs when people make a virtuous choice that permits them to make a poor choice later on, such as when someone 'earns' a weekend binge by avoiding alcohol all week.
Although the overall rate of admissions to substance abuse treatment in the U.S. remained stable between 1998 and 2008, at about 770 admissions for every 100,000 persons in the population, a new study shows striking changes and variations in admission rates by region. For example, the rate of admissions for alcohol as the primary drug has declined by 15 percent nationally. However admission rates for alcohol in West North Central states (Ark., Iowa, Kan., Minn., Mo., N.D., Neb. and S.D.) remained the same.
Ligand Pharmaceuticals Incorporated partner GlaxoSmithKline announced that today, the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion recommending marketing authorization for GSK's REVOLADE (eltrombopag) as a treatment for low platelet counts (thrombocytopenia) in adult patients with chronic hepatitis C infection, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy
Imagine if your computer only allowed you to see one line at a time, no matter what you were doing - reading e-mail, looking at a Web site, doing research. That's the challenge facing blind computer users today. But new research from North Carolina State University is moving us closer to the development of a display system that would allow the blind to take full advantage of the Web and other computer applications.
› Verified 1 days ago